Login to Your Account

Drug Prices Take Center Stage to Cut Health Care Costs

By Mari Serebrov

Friday, July 22, 2011
Casting biopharma as a villain in the ongoing saga of federal deficits and increased health care costs, a Senate committee is looking for ways to strengthen the Centers for Medicare & Medicaid Services' (CMS) role in containing prescription drug prices

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription